LPI (LP Information)' newest research report, the “Drug Discovery Enzymes Industry Forecast” looks at past sales and reviews total world Drug Discovery Enzymes sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Discovery Enzymes sales for 2023 through 2029. With Drug Discovery Enzymes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Discovery Enzymes industry.
This Insight Report provides a comprehensive analysis of the global Drug Discovery Enzymes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Discovery Enzymes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Discovery Enzymes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery Enzymes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery Enzymes.
The global Drug Discovery Enzymes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Discovery Enzymes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Discovery Enzymes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Discovery Enzymes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Discovery Enzymes players cover Sigma-Aldrich Co. LLC., Kaneka Corporation, Actelion Pharmaceuticals Ltd, Genesis Biotechnology Group, Suven Life Sciences Limited, Enzo Life Sciences and Merck KGaA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery Enzymes market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Active Kinases
Ubiquitin
Methyltransferases
Deacetylases (hdacs)
Phosphodiesterases (pdes)
Others
Segmentation by application
Pharmaceutical and Biotechnology Company
Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sigma-Aldrich Co. LLC.
Kaneka Corporation
Actelion Pharmaceuticals Ltd
Genesis Biotechnology Group
Suven Life Sciences Limited
Enzo Life Sciences
Merck KGaA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drug Discovery Enzymes market?
What factors are driving Drug Discovery Enzymes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Discovery Enzymes market opportunities vary by end market size?
How does Drug Discovery Enzymes break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Drug Discovery Enzymes Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Drug Discovery Enzymes by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Drug Discovery Enzymes by Country/Region, 2018, 2022 & 2029 2.2 Drug Discovery Enzymes Segment by Type 2.2.1 Active Kinases 2.2.2 Ubiquitin 2.2.3 Methyltransferases 2.2.4 Deacetylases (hdacs) 2.2.5 Phosphodiesterases (pdes) 2.2.6 Others 2.3 Drug Discovery Enzymes Sales by Type 2.3.1 Global Drug Discovery Enzymes Sales Market Share by Type (2018-2023) 2.3.2 Global Drug Discovery Enzymes Revenue and Market Share by Type (2018-2023) 2.3.3 Global Drug Discovery Enzymes Sale Price by Type (2018-2023) 2.4 Drug Discovery Enzymes Segment by Application 2.4.1 Pharmaceutical and Biotechnology Company 2.4.2 Research Institutes 2.4.3 Others 2.5 Drug Discovery Enzymes Sales by Application 2.5.1 Global Drug Discovery Enzymes Sale Market Share by Application (2018-2023) 2.5.2 Global Drug Discovery Enzymes Revenue and Market Share by Application (2018-2023) 2.5.3 Global Drug Discovery Enzymes Sale Price by Application (2018-2023) 3 Global Drug Discovery Enzymes by Company 3.1 Global Drug Discovery Enzymes Breakdown Data by Company 3.1.1 Global Drug Discovery Enzymes Annual Sales by Company (2018-2023) 3.1.2 Global Drug Discovery Enzymes Sales Market Share by Company (2018-2023) 3.2 Global Drug Discovery Enzymes Annual Revenue by Company (2018-2023) 3.2.1 Global Drug Discovery Enzymes Revenue by Company (2018-2023) 3.2.2 Global Drug Discovery Enzymes Revenue Market Share by Company (2018-2023) 3.3 Global Drug Discovery Enzymes Sale Price by Company 3.4 Key Manufacturers Drug Discovery Enzymes Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Drug Discovery Enzymes Product Location Distribution 3.4.2 Players Drug Discovery Enzymes Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Drug Discovery Enzymes by Geographic Region 4.1 World Historic Drug Discovery Enzymes Market Size by Geographic Region (2018-2023) 4.1.1 Global Drug Discovery Enzymes Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Drug Discovery Enzymes Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Drug Discovery Enzymes Market Size by Country/Region (2018-2023) 4.2.1 Global Drug Discovery Enzymes Annual Sales by Country/Region (2018-2023) 4.2.2 Global Drug Discovery Enzymes Annual Revenue by Country/Region (2018-2023) 4.3 Americas Drug Discovery Enzymes Sales Growth 4.4 APAC Drug Discovery Enzymes Sales Growth 4.5 Europe Drug Discovery Enzymes Sales Growth 4.6 Middle East & Africa Drug Discovery Enzymes Sales Growth 5 Americas 5.1 Americas Drug Discovery Enzymes Sales by Country 5.1.1 Americas Drug Discovery Enzymes Sales by Country (2018-2023) 5.1.2 Americas Drug Discovery Enzymes Revenue by Country (2018-2023) 5.2 Americas Drug Discovery Enzymes Sales by Type 5.3 Americas Drug Discovery Enzymes Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Drug Discovery Enzymes Sales by Region 6.1.1 APAC Drug Discovery Enzymes Sales by Region (2018-2023) 6.1.2 APAC Drug Discovery Enzymes Revenue by Region (2018-2023) 6.2 APAC Drug Discovery Enzymes Sales by Type 6.3 APAC Drug Discovery Enzymes Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Drug Discovery Enzymes by Country 7.1.1 Europe Drug Discovery Enzymes Sales by Country (2018-2023) 7.1.2 Europe Drug Discovery Enzymes Revenue by Country (2018-2023) 7.2 Europe Drug Discovery Enzymes Sales by Type 7.3 Europe Drug Discovery Enzymes Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Drug Discovery Enzymes by Country 8.1.1 Middle East & Africa Drug Discovery Enzymes Sales by Country (2018-2023) 8.1.2 Middle East & Africa Drug Discovery Enzymes Revenue by Country (2018-2023) 8.2 Middle East & Africa Drug Discovery Enzymes Sales by Type 8.3 Middle East & Africa Drug Discovery Enzymes Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Drug Discovery Enzymes 10.3 Manufacturing Process Analysis of Drug Discovery Enzymes 10.4 Industry Chain Structure of Drug Discovery Enzymes 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Drug Discovery Enzymes Distributors 11.3 Drug Discovery Enzymes Customer 12 World Forecast Review for Drug Discovery Enzymes by Geographic Region 12.1 Global Drug Discovery Enzymes Market Size Forecast by Region 12.1.1 Global Drug Discovery Enzymes Forecast by Region (2024-2029) 12.1.2 Global Drug Discovery Enzymes Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Drug Discovery Enzymes Forecast by Type 12.7 Global Drug Discovery Enzymes Forecast by Application 13 Key Players Analysis 13.1 Sigma-Aldrich Co. LLC. 13.1.1 Sigma-Aldrich Co. LLC. Company Information 13.1.2 Sigma-Aldrich Co. LLC. Drug Discovery Enzymes Product Portfolios and Specifications 13.1.3 Sigma-Aldrich Co. LLC. Drug Discovery Enzymes Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Sigma-Aldrich Co. LLC. Main Business Overview 13.1.5 Sigma-Aldrich Co. LLC. Latest Developments 13.2 Kaneka Corporation 13.2.1 Kaneka Corporation Company Information 13.2.2 Kaneka Corporation Drug Discovery Enzymes Product Portfolios and Specifications 13.2.3 Kaneka Corporation Drug Discovery Enzymes Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Kaneka Corporation Main Business Overview 13.2.5 Kaneka Corporation Latest Developments 13.3 Actelion Pharmaceuticals Ltd 13.3.1 Actelion Pharmaceuticals Ltd Company Information 13.3.2 Actelion Pharmaceuticals Ltd Drug Discovery Enzymes Product Portfolios and Specifications 13.3.3 Actelion Pharmaceuticals Ltd Drug Discovery Enzymes Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Actelion Pharmaceuticals Ltd Main Business Overview 13.3.5 Actelion Pharmaceuticals Ltd Latest Developments 13.4 Genesis Biotechnology Group 13.4.1 Genesis Biotechnology Group Company Information 13.4.2 Genesis Biotechnology Group Drug Discovery Enzymes Product Portfolios and Specifications 13.4.3 Genesis Biotechnology Group Drug Discovery Enzymes Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Genesis Biotechnology Group Main Business Overview 13.4.5 Genesis Biotechnology Group Latest Developments 13.5 Suven Life Sciences Limited 13.5.1 Suven Life Sciences Limited Company Information 13.5.2 Suven Life Sciences Limited Drug Discovery Enzymes Product Portfolios and Specifications 13.5.3 Suven Life Sciences Limited Drug Discovery Enzymes Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Suven Life Sciences Limited Main Business Overview 13.5.5 Suven Life Sciences Limited Latest Developments 13.6 Enzo Life Sciences 13.6.1 Enzo Life Sciences Company Information 13.6.2 Enzo Life Sciences Drug Discovery Enzymes Product Portfolios and Specifications 13.6.3 Enzo Life Sciences Drug Discovery Enzymes Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Enzo Life Sciences Main Business Overview 13.6.5 Enzo Life Sciences Latest Developments 13.7 Merck KGaA 13.7.1 Merck KGaA Company Information 13.7.2 Merck KGaA Drug Discovery Enzymes Product Portfolios and Specifications 13.7.3 Merck KGaA Drug Discovery Enzymes Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Merck KGaA Main Business Overview 13.7.5 Merck KGaA Latest Developments 14 Research Findings and Conclusion